Primary Open-Angle Glaucoma

Primary open-angle glaucoma (POAG) is a chronic, bilateral, insidiously progressive optic neuropathy characterised by acquired loss of retinal ganglion cells and their axons, producing a typical pattern of optic disc cupping and visual field loss, classically (but not always) associated with raised intraocular pressure (IOP) in the presence of an open, normal-appearing anterior chamber angle. It is the commonest form of glaucoma worldwide and a leading cause of irreversible blindness. The disease is painless and asymptomatic until late, hence the eponym "the sneak thief of sight."

Definition and classification

Glaucoma is no longer defined purely by raised IOP; the modern definition centres on a characteristic optic neuropathy with corresponding visual field loss, with IOP being the only consistently modifiable risk factor. POAG specifically requires an open angle on gonioscopy and the absence of a secondary cause.

The broader glaucoma family is classified as below.

Type	Angle	IOP	Onset	Key feature
POAG	Open	Usually raised (>21 mmHg)	Chronic, painless	Trabecular meshwork dysfunction
Normal-tension glaucoma (NTG)	Open	≤21 mmHg (normal)	Chronic	Vascular/disc susceptibility
Ocular hypertension (OHT)	Open	Raised	—	No disc/field damage (yet)
Primary angle-closure glaucoma	Closed/occludable	Raised, often acute	Acute or chronic	Pupillary block
Secondary glaucomas	Either	Raised	Variable	Identifiable cause (steroid, uveitic, neovascular, pseudoexfoliative, pigmentary, traumatic)

High-yield: POAG = open angle + raised IOP + optic neuropathy + glaucomatous visual field defect, with NO secondary cause. If any of these is "secondary" (e.g., pseudoexfoliation, pigment dispersion, steroid use), it is no longer "primary."

A clinically useful trio to separate is POAG vs NTG vs OHT — all have open angles. POAG has high IOP + damage; NTG has normal IOP + damage; OHT has high IOP + NO damage.

Epidemiology and risk factors

• Typically presents after 40 years; prevalence rises with age.
• Most important risk factors: raised IOP, increasing age, positive family history (first-degree relative increases risk several-fold), African/Afro-Caribbean ethnicity (earlier onset, more aggressive), myopia, and thin central corneal thickness (CCT).
• Systemic associations: diabetes mellitus, systemic hypertension, and vasospastic conditions (more linked to NTG).
• Thin cornea is an independent risk factor (from the Ocular Hypertension Treatment Study, OHTS) — a thin cornea both falsely lowers measured IOP and is itself a biological marker of risk.

High-yield: The Ocular Hypertension Treatment Study (OHTS) established central corneal thickness as a powerful predictor of conversion from OHT to POAG. Thin CCT → higher true IOP than measured → higher risk.

Etiology and pathophysiology

The fundamental defect in POAG is increased resistance to aqueous outflow at the trabecular meshwork, specifically the juxtacanalicular (cribriform) meshwork adjacent to the inner wall of Schlemm's canal — NOT increased aqueous production. The angle remains anatomically open; the obstruction is at the microscopic/biochemical level (thickening of trabecular beams, loss of trabecular endothelial cells, accumulation of extracellular matrix).

Aqueous dynamics recap: Aqueous is produced by the ciliary body (non-pigmented epithelium) → flows from posterior chamber through the pupil → anterior chamber → drains chiefly via the trabecular meshwork → Schlemm's canal → episcleral veins (conventional/~80–90%), with the remainder via the uveoscleral (unconventional) route. In POAG the conventional outflow is impaired.

Mechanism of optic nerve damage — two principal (likely additive) theories:

1. Mechanical theory: Raised IOP directly compresses axons at the lamina cribrosa, blocking axoplasmic flow and causing retinal ganglion cell apoptosis.
2. Vascular (ischaemic) theory: Impaired perfusion of the optic nerve head; this dominates in NTG, where IOP is normal but the disc is vascularly vulnerable.

The result is loss of retinal ganglion cell axons, thinning of the retinal nerve fibre layer (RNFL), and progressive excavation (cupping) of the optic disc.

Pathophysiology flow: Trabecular meshwork outflow resistance ↑ → IOP ↑ → lamina cribrosa stress + optic nerve head ischaemia → axoplasmic flow block → retinal ganglion cell apoptosis → RNFL thinning → cupping ↑ → arcuate/nasal-step field defects → tunnel vision → end-stage blindness.

Clinical features

POAG is insidious, bilateral (often asymmetric), and painless. Because central vision and acuity are preserved until very late, patients are frequently asymptomatic and detected on routine examination.

• Early: No symptoms. Vision and acuity normal.
• Mid: Peripheral / paracentral field loss the patient does not notice (the brain "fills in").
• Late: Constriction to a central tunnel and a residual temporal island of vision; eventually total blindness.
• Central acuity is preserved late because the papillomacular bundle is relatively spared until end-stage.

Visual field defects (sequence)

The earliest detectable defects arise in the arcuate (Bjerrum) area, 10–20° from fixation, corresponding to the arcuate nerve fibre bundles.

Order of field loss:

1. Isolated paracentral scotomas + baring of the blind spot (early).
2. Nasal step (of Rönne) — a step-off at the horizontal nasal meridian; classic.
3. Arcuate (Bjerrum / Seidel) scotoma arching from the blind spot.
4. Ring/double-arcuate scotoma.
5. Tunnel vision with a sparse temporal island and central tube.

High-yield: The nasal step (Rönne's nasal step) and arcuate/Bjerrum scotoma are the hallmark early glaucomatous field defects. They respect the horizontal meridian because nerve fibres do not cross it.

Signs at the optic disc

The disc changes are central to diagnosis and are heavily tested.

Disc sign	Description
Increased cup–disc (C:D) ratio	>0.6, or asymmetry >0.2 between the two eyes
Vertical elongation of the cup	Preferential loss of superior/inferior neuroretinal rim
ISNT rule violation	Normal rim thickness Inferior > Superior > Nasal > Temporal; loss of this order suggests glaucoma
Notching of the neuroretinal rim	Focal rim loss, esp. inferotemporal/superotemporal
Bayonetting of vessels	Vessels bend sharply at the cup edge
Bared circumlinear / nasalisation of vessels	Vessels pushed nasally
Disc (splinter) haemorrhages	"Drance haemorrhage" — flame-shaped at disc margin; marker of progression, common in NTG
Laminar dot sign	Visible grey dots of the lamina cribrosa in deep cups
Peripapillary atrophy	Beta-zone enlargement

High-yield: A vertical C:D asymmetry of >0.2 between fellow eyes, or violation of the ISNT rule, is strongly suggestive of glaucoma even before field loss. A Drance (splinter) haemorrhage signals ongoing damage and is especially associated with normal-tension glaucoma.

Diagnosis and investigations

Glaucoma diagnosis is multimodal — no single test is sufficient. The "core four" are tonometry, gonioscopy, optic disc/RNFL assessment, and perimetry, supported by pachymetry.

1. Tonometry (IOP measurement)

• Normal IOP: 10–21 mmHg (mean ~15–16; statistically 2 SD above the mean ≈ 21).
• Gold standard: Goldmann applanation tonometry (GAT), based on the Imbert–Fick principle. Uses fluorescein + cobalt-blue light; endpoint is when the inner edges of two semicircular mires just touch.
• Diurnal variation is increased in glaucoma (normal <5 mmHg; glaucoma often >8–10 mmHg); IOP is typically highest in the early morning.

High-yield: Goldmann applanation tonometry is the gold standard and is based on the Imbert–Fick law (Pressure = Force / Area). A thin cornea causes underestimation and a thick cornea overestimation of true IOP — always correlate with pachymetry.

2. Gonioscopy

Mandatory to confirm the angle is open and to exclude angle-closure and secondary causes (neovascularisation, pigment, pseudoexfoliative material, recession). The Goldmann/indirect goniolens is used. Open angle = the angle structures (Schwalbe's line → trabecular meshwork → scleral spur → ciliary body band) are visible.

3. Pachymetry (central corneal thickness)

Essential for interpreting IOP and stratifying risk (OHTS). Average CCT ≈ 540–545 µm.

4. Optic nerve head & RNFL imaging

• Clinical: Slit-lamp stereoscopic disc examination (78D/90D lens).
• OCT (optical coherence tomography): Objective, reproducible quantification of RNFL thickness and ganglion cell complex — the most useful structural tool for early detection and monitoring.

5. Perimetry (visual fields)

Standard automated perimetry (SAP), e.g. Humphrey 24-2/30-2, is the reference standard for functional damage. Reports key indices: MD (mean deviation) and PSD (pattern standard deviation); the glaucoma hemifield test flags asymmetry across the horizontal meridian.

High-yield (structure–function gap): Roughly 30–50% of retinal ganglion cells may be lost before standard perimetry detects a defect. Hence structural imaging (OCT/disc) often shows damage before fields — investigation of choice for early disease is OCT RNFL, while perimetry confirms functional loss and tracks progression.

Management

The only proven, modifiable target is IOP. Therapy aims to lower IOP to a target pressure (an individualised level, often a 20–30% reduction from baseline, lower for advanced disease) that halts progression. Damage already done is irreversible — treatment prevents further loss.

Treatment ladder (flow): Medical therapy (topical) → Laser trabeculoplasty → Incisional surgery (trabeculectomy) ± antimetabolites → Glaucoma drainage devices / cyclodestruction.

Medical therapy

Class	Examples	Mechanism	Key cautions / facts
Prostaglandin analogues	Latanoprost, travoprost, bimatoprost	↑ uveoscleral outflow	First-line / DOC; once-daily; best IOP lowering; side effects: iris/periocular hyperpigmentation, eyelash growth, conjunctival hyperaemia, CMO/uveitis reactivation
Beta-blockers	Timolol, betaxolol	↓ aqueous production	Avoid in asthma/COPD, bradycardia, heart block (betaxolol = β1-selective, relatively safer)
Alpha-2 agonists	Brimonidine, apraclonidine	↓ production + ↑ uveoscleral outflow	Contra in infants (CNS depression, apnoea); allergic conjunctivitis
Topical CAIs	Dorzolamide, brinzolamide	↓ production (ciliary epithelium)	Sulphonamide allergy; metallic taste
Rho-kinase inhibitors	Netarsudil	↑ trabecular outflow (+↓ episcleral venous pressure)	Conjunctival hyperaemia, corneal verticillata
Cholinergics (miotics)	Pilocarpine	↑ trabecular outflow via ciliary muscle contraction	Largely historical now; brow ache, miosis, retinal detachment risk
Systemic CAI	Acetazolamide	↓ production	Short-term/acute use; paraesthesia, metabolic acidosis, stones

High-yield: Prostaglandin analogues (e.g., latanoprost) are the first-line drug of choice in POAG — most effective, once-daily, minimal systemic effects. Their mechanism is increased uveoscleral outflow. Timolol (beta-blocker) is contraindicated in asthma/COPD and heart block.

Laser

Selective laser trabeculoplasty (SLT) targets the trabecular meshwork to enhance outflow. The LiGHT trial supports SLT as a reasonable first-line alternative to drops. Argon laser trabeculoplasty (ALT) is the older variant.

Surgery

• Trabeculectomy is the classic filtering surgery (creates a guarded fistula → subconjunctival bleb), often with antimetabolites mitomycin-C / 5-fluorouracil to reduce scarring. Indicated when medical/laser therapy fails to reach target.
• Glaucoma drainage devices (Ahmed, Baerveldt) for refractory/secondary cases.
• MIGS (minimally invasive glaucoma surgery) for mild–moderate disease, often combined with cataract surgery.

Normal-tension glaucoma (NTG) — special note

Glaucomatous disc and field damage with IOP consistently ≤21 mmHg. Features that point to NTG over POAG: disc (Drance) haemorrhages, paracentral/denser field defects closer to fixation, peripapillary atrophy, and systemic vascular dysregulation (migraine, Raynaud's, nocturnal hypotension, sleep apnoea). The Collaborative Normal-Tension Glaucoma Study showed that lowering IOP by ~30% still slows progression, confirming IOP matters even when "normal." Always exclude mimics (previous IOP spikes, intermittent angle closure, optic neuropathies, intracranial lesions).

Complications

• Progressive, irreversible visual field loss → tunnel vision → blindness.
• Reduced quality of life, falls, loss of driving ability.
• Treatment-related: beta-blocker systemic effects (bronchospasm, bradycardia); bleb-related infection/endophthalmitis and bleb leaks after trabeculectomy; hypotony and choroidal effusion; cataract progression.

Key differentials

Condition	Distinguishing point
Primary angle-closure glaucoma	Closed/occludable angle on gonioscopy, may present acutely (pain, halos, mid-dilated pupil, hazy cornea)
Ocular hypertension	Raised IOP but normal disc and fields
Normal-tension glaucoma	Typical damage with normal IOP
Secondary open-angle glaucomas	Pseudoexfoliation (flaky deposits on lens/pupil margin), pigment dispersion (Krukenberg spindle), steroid-induced, neovascular, uveitic, traumatic angle recession
Physiological large cup	Symmetric, large disc, normal rim (obeys ISNT), normal fields, stable
Non-glaucomatous optic neuropathy	Pallor exceeds cupping; consider compressive lesion (neuroimaging) if pattern atypical

High-yield: Pallor out of proportion to cupping suggests a non-glaucomatous (e.g., compressive) optic neuropathy → image the optic pathway. In glaucoma, cupping predominates over pallor.

Mnemonics and named facts

• ISNT rule: healthy neuroretinal rim thickness order = Inferior > Superior > Nasal > Temporal. Violation → suspect glaucoma.
• Field defect mnemonic — "Para-Nasal-Arc-Ring-Tunnel": Paracentral scotoma → Nasal step → Arcuate (Bjerrum) → Ring → Tunnel.
• Drug classes lowering production vs increasing outflow: Production ↓ = Beta-blockers, CAIs, Alpha-agonists (BCA); Outflow ↑ = Prostaglandins (uveoscleral), Pilocarpine & Rho-kinase (trabecular).
• Eponyms: Rönne's nasal step, Bjerrum/Seidel scotoma, Drance haemorrhage, Schlemm's canal, lamina cribrosa, Imbert–Fick (applanation), Krukenberg spindle (pigmentary), Schwalbe's line/scleral spur (gonioscopy).
• Cut-offs: IOP normal 10–21 mmHg; C:D suspicious if >0.6 or asymmetry >0.2; CCT mean ~540 µm; ~40% RGCs lost before perimetric defect.

Recently asked / exam angle

• First-line drug of choice for POAG → prostaglandin analogue (latanoprost); mechanism = increased uveoscleral outflow (very frequently asked).
• Gold standard tonometry → Goldmann applanation; principle = Imbert–Fick. Effect of corneal thickness on readings.
• Earliest visual field defect → paracentral scotoma / nasal step; arcuate (Bjerrum) scotoma respects horizontal meridian.
• Site of obstruction in POAG → juxtacanalicular trabecular meshwork (NOT increased aqueous production).
• Differentiating POAG vs NTG vs OHT (table-based questions); role of CCT/OHTS.
• ISNT rule and disc signs (notching, bayonetting, Drance haemorrhage).
• Contraindication of timolol → asthma/COPD, heart block, bradycardia.
• Trabeculectomy as surgical procedure of choice + use of mitomycin-C/5-FU.
• Structure–function gap — OCT detects damage earlier than perimetry.
• Image-based: glaucomatous disc photo (large vertical cup, notch, bayonetting) and Humphrey field printout (arcuate defect / nasal step).

Rapid revision

1. POAG = open angle + chronic painless optic neuropathy + glaucomatous field loss; IOP usually >21 mmHg but not mandatory.
2. Core defect = ↑ outflow resistance at juxtacanalicular trabecular meshwork; aqueous production is normal.
3. Normal IOP 10–21 mmHg; Goldmann applanation tonometry = gold standard (Imbert–Fick principle).
4. Thin cornea underestimates IOP and is an independent risk factor (OHTS).
5. Earliest fields: paracentral scotoma and nasal step (Rönne); then arcuate/Bjerrum, ring, tunnel vision; central acuity preserved till late.
6. Disc: vertical C:D >0.6 or asymmetry >0.2, ISNT violation, notching, bayonetting, Drance haemorrhage (esp. NTG).
7. OCT RNFL detects damage early (≈30–50% RGC loss before perimetry shows it); SAP/Humphrey 24-2 for functional confirmation and monitoring.
8. Gonioscopy is mandatory to confirm open angle and exclude secondary/angle-closure causes.
9. First-line drug = prostaglandin analogue (latanoprost) → ↑ uveoscleral outflow; SE: iris/lash/periocular pigmentation.
10. Beta-blockers, alpha-2 agonists, CAIs ↓ production; timolol contraindicated in asthma/COPD/heart block.
11. Ladder: drops → SLT → trabeculectomy (+ mitomycin-C/5-FU) → drainage device.
12. NTG = damage with normal IOP; lowering IOP ~30% still slows progression (CNTGS). Pallor > cupping → think non-glaucomatous/compressive optic neuropathy.